Maxime Feyeux
Founder of TreeFrog Therapeutics
Maxime Feyeux is President, CSO and co-founder of TreeFrog Therapeutics whose proprietory C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment. Prior to founding TreeFrog in 2018, Feyeux worked as a maturation engineer at Aquitaine Science Transfert and completed a post-doctoral degree at Bordeaux’s Institut des Maladies Neurodégénératives. He also has a post-doctoral degree from the University of Geneva and completed his PhD in neurobiology and neurosciences at the Université d’Evry-Val d’Essone.
The rest of the content is only available if you are logged in.
RECOMMENDED